Work

A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity

Year: 2014

Type: article

Source: Anti-Cancer Drugs

DOI: 10.1097/cad.0000000000000160

Authors: Daqiang Zhu, Xiaofei Wang, Yue Shang, Yi Li, Wenguo Jiang, Liang Li, Shu-zhen Chen

Institution: Chinese Academy of Medical Sciences & Peking Union Medical College

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Natural Science Foundation of China, National Science and Technology Major Project

OpenAlex ID: W2313389558

FWCI: 0.259

Cites: 32

Cited by: 5

Related to: 10